Improved oral anticancer medication (OAM) adherence/toxicity assessment documentation.

Authors

null

Lisa Holle

University of Connecticut School of Pharmacy, Storrs, CT

Lisa Holle, Andrea Moran, Margaret Savage, Michael Kenneth Keng

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Quality Care Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Quality, Safety, and Implementation Science,Cost, Value, and Policy,Patient Experience,Survivorship

Sub Track

Quality Improvement Research and Implementation Science

Citation

JCO Oncol Pract 19, 2023 (suppl 11; abstr 409)

DOI

10.1200/OP.2023.19.11_suppl.409

Abstract #

409

Poster Bd #

H19

Abstract Disclosures

Similar Posters

First Author: Carolyn Russo

First Author: Brian Hunis

Poster

2023 ASCO Quality Care Symposium

Improving timely melphalan administration completion for recipients of autologous stem cell transplant.

Improving timely melphalan administration completion for recipients of autologous stem cell transplant.

First Author: Michael Williams

Poster

2023 ASCO Quality Care Symposium

Reducing 30% of waiting time in the administration of antineoplastic oral drugs in patients with urological cancer.

Reducing 30% of waiting time in the administration of antineoplastic oral drugs in patients with urological cancer.

First Author: Amaya Diaz De Cerio